Clarification needed for pembrolizumab as adjuvant therapy in clear cell renal cell carcinoma – Authors' reply. Issue 1 (January 2023)

Record Type:: Journal Article
Title:: Clarification needed for pembrolizumab as adjuvant therapy in clear cell renal cell carcinoma – Authors' reply. Issue 1 (January 2023)
Main Title:: Clarification needed for pembrolizumab as adjuvant therapy in clear cell renal cell carcinoma – Authors' reply
Authors:: Powles, Thomas
Burgents, Joseph E
Xu, Lei
Choueiri, Toni K
Abstract:
Is Part Of:: Lancet oncology. Volume 24:Issue 1(2023)
Journal:: Lancet oncology
Issue:: Volume 24:Issue 1(2023)
Issue Display:: Volume 24, Issue 1 (2023)
Year:: 2023
Volume:: 24
Issue:: 1
Issue Sort Value:: 2023-0024-0001-0000
Page Start:: e1
Page End:: e2
Publication Date:: 2023-01
Subjects:: Oncology -- Periodicals
Neoplasms -- Periodicals
Cancérologie -- Périodiques
Oncologie
Oncology
Periodicals
Electronic journals
616.994005
Journal URLs:: http://www.sciencedirect.com/science/journal/14702045 ↗
http://www.elsevier.com/journals ↗
DOI:: 10.1016/S1470-2045(22)00740-9 ↗
Languages:: English
ISSNs:: 1470-2045
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 5146.090000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store
Ingest File:: 24943.xml